IBM stock price just collapsed

IBM beat Q2 2025 profit expectations, reporting $17 billion in revenue and $2.80 adjusted EPS, attributing its revenue growth to AI. However, despite exceeding top-line forecasts, its stock fell 6.02% on July 24 as investors focused on the software segment's performance, which, at $7.4 billion, only met expectations despite 10% growth, disappointing those anticipating stronger momentum. This mixed sentiment is echoed by analysts, with UBS reiterating a 'Sell' rating due to concerns about the software segment's future growth despite raising its price target, while Jefferies maintained a 'Hold'.

Analysis

International Business Machines (NYSE: IBM) reported a significant beat for Q2 2025, with revenue of $17 billion surpassing the $16.6 billion forecast and adjusted EPS of $2.80 exceeding the projected $2.65. This 8% year-over-year revenue growth was largely attributed to its artificial intelligence initiatives. Despite the strong headline figures, the stock reacted negatively, falling 6.02% in pre-market trading. The sell-off was triggered by investor disappointment in the company's largest business unit, the software segment. Although this segment's revenue grew 10% from the prior year to $7.4 billion, it only met analyst expectations rather than exceeding them. This in-line performance was insufficient to sustain momentum for a stock that had already gained 28% year-to-date, a performance that had even outpaced Nvidia. The cautious sentiment is mirrored by analysts, with UBS reiterating a "Sell" rating over concerns that lagging software growth could jeopardize projected 5% growth in 2026, while Jefferies maintained a neutral "Hold" rating.

Key Decisions for Investors

• Investors should scrutinize the performance of IBM's software segment in coming quarters, as its failure to exceed high expectations was the primary driver of the post-earnings stock decline despite a top-and-bottom-line beat.
• Given the stock's 28% year-to-date rally preceding the report, the subsequent 6% drop suggests the market had priced in perfection, warranting caution until the company can demonstrate accelerating growth in its core software division.
• Note the cautious analyst outlook, such as UBS's reiterated 'Sell' rating and concerns over 2026 growth, which signal potential headwinds and temper the otherwise positive headline results.